The #EyeCareSupportPathway is a framework, developed by RNIB and partners across the sector, for the NHS, social care organisations, the third sector and the public to use to support the transformation of eye care and eye services.
Cornea cross-linking (CXL) is a relatively new treatment in the management of keratoconus, which may help prevent the need for corneal transplant. This paper investigates if the introduction of corneal cross-linkage has reduced the number of corneal transplants performed annually...
“It’s been brilliant – I’d much rather have cataract surgery than visit the dentist!” Carol celebrates better vision as Wakefield Eye Hospital’s 20,000th patient.
CHEC, one of the largest providers of community-based ophthalmology services in the UK, has launched an enhanced go-to-market strategy that will better align its service offerings and provision with the NHS’ evolving needs.
This comment article highlights the controversy that exists in the choice for anti-VEGF drugs used for treatment of macular oedema and wet age-related macular degeneration (AMD). Two existing licensed drugs for macular oedema are ranibizumab (Lucentis) and aflibercept (Eylea). A...